Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
CardiovascularORALGeneric

ATORVASTATIN CALCIUM

ATORVASTATIN CALCIUM

Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ATORVASTATIN CALCIUM is listed in Drugs@FDA under application 217634 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ATORVASTATIN CALCIUM Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor STRIDES PHARMA Submission history Latest submission status date: 2024-09-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATORVASTATIN CALCIUM is listed in Drugs@FDA under application 217634 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ATORVASTATIN CALCIUM Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor STRIDES PHARMA Submission history Latest submission status date: 2024-09-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.